Itraconazole 1993 was listed in China in February, and it has oral capsules and oral solutions. It was patented by Xi Anjansang Company in China and imported and sold separately in China. Itraconazole 1993 is a new drug to replace amphotericin B in the treatment of invasive aspergillosis, which has been listed in more than 50 countries and regions around the world.
Itraconazole has a broad antifungal spectrum, which can effectively interfere with the 14-a demethylation of fungal cytochrome P450 and inhibit the formation of ergosterol, and has a strong effect on superficial and deep fungal infections. Capsules are often used to treat refractory onychomycosis, oral liquid is more suitable for the treatment of fungal infections in oral cavity and buccal mucosa, and intravenous injection is used for the treatment of high-risk patients. It has the characteristics of high lipophilicity and many horniness, and can be maintained for a long time after stopping taking medicine, with lasting drug effect. And has good antibacterial effect on superficial fungal infections such as bacteria, fungi and the like.
How much to eat depends on the instructions.